Valrubicin for bladder cancer.
D002278:Carcinoma in Situ / Q000188:drug therapy* / Q000378:metabolism; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000378:metabolism
C016163:valrubicin; D004317:Doxorubicin